Medical Hypotheses
Volume 57, Issue 2 , Pages 151-155 , August 2001

The possible role of vitamin K deficiency in the pathogenesis of Alzheimer’s disease and in augmenting brain damage associated with cardiovascular disease

Received 17 October 2000 ,Accepted 9 January 2001.

References 

    REFERENCES
  1. Evans DE, Scherr PA, Cook NR. Estimated prevalence of Alzheimer’s disease in the United States. The Milbank Qtrly. 1990;68:267–269
  2. Consensus report of the working group on: “Molecular and biochemical markers of Alzheimer’s disease”. Neurobiology of Aging, 1998, 19, 109, 116.
  3. Mayeux R, Saunders AM, Shea S. Utility of the apolipoprotein-E genotype in the diagnosis of Alzheimer’s disease. New Engl J Med. 1998;338:506–511
  4. Flynn BI. Pharmacologic management of Alzheimer’s disease. Ann Pharmacother. 1999;33:178–187, 188–197, 840–849
  5. Knopman, D. S. Advances in methodology and current prospects for primary drug therapies for Alzheimer’s disease. Hooper, N.E. Methods in Molecular Medicine, Vol. 32. Alzheimer’s disease: methods and protocols, Totowa NJ, Humana Press, 2000: 45–60.
  6. Vermeer C, Jie K-S, Knapen MJH. Role of vitamin K in metabolic bone disease. Annu Rev Nutrition. 1995;15:1–22
  7. Tamatani M, Morimoto S, Nakajima M. Decreased circulating levels of vitamin K and 25-hydroxyvitamin D in osteopenic elderly men. Metabolism. 1998;47:195–199
  8. Kohlmeier M, Solomon A, Saupe J, Shearer MJ. Transport of vitamin K to bones in humans. J Nutr. 1996;126:1192S–1196S
  9. Saupe J, Shearer MJ, Kohlmeier M. Phylloquinone transport and its influence on γ-carboxyglutamate residues of osteocalcin in patients on hemodialysis. Am J Clin Nutr. 1993;58:204–208
  10. Cauley JA, Zmuda JM, Yaffe K. Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk – the study of osteoporotic fractures. J Bone Miner Res. 1999;14:1175–1181
  11. Johnston JM, Cauley JA, Ganguly M. APOE 4 and hip fracture risk in a community-based study of older adults. J Am Geriatr Soc. 1999;47:1342–1345
  12. Thijssen HHW, Drittij-Reijnders MJ. Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4. Br J Nutr. 1994;72:415–425
  13. Sundaram KS, Fan J-H, Engelke JA. Vitamin K status influences brain sulfatide metabolism in young mice and rats. J Nutr. 1996;126:2746–2751
  14. Pauli RM, Haun JM. Intrauterine effects of coumarin derivatives. Dev Brain Dysfunct. 1993;6:229–247
  15. Lev M, Milford AF. Effect of vitamin K depletion and restoration on sphingolipid metabolism in Bacteroides melaninogenicus. J Lipid Res. 1972;13:364–370
  16. Sundaram KS, Lev M. Warfarin administration reduces synthesis of sulfatides and other sphingolipids in brain. J Lipid Res. 1988;29:1745–1749
  17. Sundaram KS, Lev M. Regulation of sulfotransferase activity by vitamin K in mouse brain. Arch Biochem Biophys. 1990;277:109–113
  18. Lindahl B, Eriksson L, Spillmann D. Selective loss of cerebral keratan sulfate in Alzheimer’s disease. J Biol Chem. 1996;271:16991–16994
  19. Margolis RK, Margolis RU. Nervous tissue proteoglycans. Experientia. 1993;49:429–446
  20. Scranton TW, Iwata M, Carlson SS. The SV-2 protein of synaptic vesicles is a keratan sulfate proteoglycan. J Neurochem. 1993;61:29–44
  21. Bahr BA, Noremberg K, Rogers GA. Linkage of the acetylcholine transporter-vesamicol receptor to proteoglycan in synaptic vesicles. Biochemistry. 1992;31:5778–5784
  22. Snow AD, Nochlin D, Sekiguchi R, Carlson SS. Identification and immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer’s disease. Exp Neurol. 1996;138:305
  23. Prieto AL, Weber JL, Tracy S. Gas 6, a ligand for the receptor tyrosine kinase tyro 3, is widely expressed in the central nervous system. Brain Res. 1999;816:646–661
  24. Nakano T, Kawamoto K, Kishino J. Requirement of γ-carboxyglutamic acid residues for the biological activity of Gas 6: contribution of endogenous Gas 6 to the proliferation of vascular smooth muscle cells. Biochem J. 1977;323:387–392
  25. Li. R-H, Chen J, Hammonds G. Identification of Gas 6 as a growth factor for human Schwann cells. J Neurosci. 1996;16:2012–2019
  26. Allen MP, Zeng C, Schneider K. Growth arrest-specific gene 6 (gas 6)/adhesion related kinase (Ark) signaling promotes gonadotropin-releasing hormone neuronal survival via extracellular signal related kinase (ERK) and Akt. Mol Endocrinol. 1999;13:191–201
  27. Saxena SP, Fan T, Li M. A novel role for vitamin K1in a tyrosine phosphorylation cascade during chick embryogenesis. J Clin Invest. 1977;99:602–607
  28. Tsaioun KI. Vitamin K-dependent proteins in the developing and aging nervous system. Nutr Revs. 1999;57:231–240
  29. De Carli C, Reed T, Miller BL. Impact of apolipoprotein E4 and vascular disease on brain morphology in men from the NHLBI twin study. Stroke. 1999;30:1548–1553

PII: S0306-9877(01)91307-6

doi: 10.1054/mehy.2001.1307

Medical Hypotheses
Volume 57, Issue 2 , Pages 151-155 , August 2001

Article Tools